With more than 50 different species of lilly pilly in Australia, and lots more cultivars, there are plenty of these handsome garden plants to choose from. Clarence reckons two worth growing for ...

With more than 50 different species of lilly pilly in Australia, and lots more cultivars, there are plenty of these handsome garden plants to choose from. Clarence reckons two worth growing for ...

Escape to the perfect blend of rural tranquillity and modern accessibility at 64 Lilly Pilly Court, Burpengary. Nestled in a peaceful alcove, this stunning acreage property offers a rare ...

Family-friendly Cul-de-sac Location Rob and Racheal of Robert James Realty welcome you to Lilly Pilly Place, a peaceful cul-de-sac in the highly desirable Wallace Heights estate. This meticulously ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...